Literature DB >> 34831456

A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory Clostridioides difficile Infection.

Tanya M Monaghan1,2, Niharika A Duggal3, Elisa Rosati4, Ruth Griffin2,5, Jamie Hughes5, Brandi Roach6, David Y Yang6, Christopher Wang6, Karen Wong6, Lynora Saxinger7, Maja Pučić-Baković8, Frano Vučković8, Filip Klicek8, Gordan Lauc8,9, Paddy Tighe10, Benjamin H Mullish11, Jesus Miguens Blanco11, Julie A K McDonald11,12, Julian R Marchesi11, Ning Xue13, Tania Dottorini13, Animesh Acharjee14, Andre Franke4, Yingrui Li15, Gane Ka-Shu Wong16, Christos Polytarchou17, Tung On Yau17, Niki Christodoulou17, Maria Hatziapostolou17, Minkun Wang15,18, Lindsey A Russell19, Dina H Kao6.   

Abstract

Fecal microbiota transplantation (FMT) is highly effective in recurrent Clostridioides difficile infection (CDI); increasing evidence supports FMT in severe or fulminant Clostridioides difficile infection (SFCDI). However, the multifactorial mechanisms that underpin the efficacy of FMT are not fully understood. Systems biology approaches using high-throughput technologies may help with mechanistic dissection of host-microbial interactions. Here, we have undertaken a deep phenomics study on four adults receiving sequential FMT for SFCDI, in which we performed a longitudinal, integrative analysis of multiple host factors and intestinal microbiome changes. Stool samples were profiled for changes in gut microbiota and metabolites and blood samples for alterations in targeted epigenomic, metabonomic, glycomic, immune proteomic, immunophenotyping, immune functional assays, and T-cell receptor (TCR) repertoires, respectively. We characterised temporal trajectories in gut microbial and host immunometabolic data sets in three responders and one non-responder to sequential FMT. A total of 562 features were used for analysis, of which 78 features were identified, which differed between the responders and the non-responder. The observed dynamic phenotypic changes may potentially suggest immunosenescent signals in the non-responder and may help to underpin the mechanisms accompanying successful FMT, although our study is limited by a small sample size and significant heterogeneity in patient baseline characteristics. Our multi-omics integrative longitudinal analytical approach extends the knowledge regarding mechanisms of efficacy of FMT and highlights preliminary novel signatures, which should be validated in larger studies.

Entities:  

Keywords:  Clostridioides difficile; fecal microbiota transplantation; host-microbial interactions; immunosenescence; systems biology

Mesh:

Substances:

Year:  2021        PMID: 34831456      PMCID: PMC8624539          DOI: 10.3390/cells10113234

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  79 in total

1.  Defective responsiveness of CD5+ B1 cells to lipopolysaccharide in cytokine production.

Authors:  Naoki Koide; Akiko Morikawa; Hiroyasu Ito; Tsuyoshi Sugiyama; Ferdaus Hassan; Shamima Islam; Gantsetseg Tumurkhuu; Isamu Mori; Tomoaki Yoshida; Takashi Yokochi
Journal:  J Endotoxin Res       Date:  2006

2.  Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.

Authors:  Dina Kao; Brandi Roach; Marisela Silva; Paul Beck; Kevin Rioux; Gilaad G Kaplan; Hsiu-Ju Chang; Stephanie Coward; Karen J Goodman; Huiping Xu; Karen Madsen; Andrew Mason; Gane Ka-Shu Wong; Juan Jovel; Jordan Patterson; Thomas Louie
Journal:  JAMA       Date:  2017-11-28       Impact factor: 56.272

Review 3.  Gut microbiota: A player in aging and a target for anti-aging intervention.

Authors:  Alexander M Vaiserman; Alexander K Koliada; Francesco Marotta
Journal:  Ageing Res Rev       Date:  2017-01-18       Impact factor: 10.895

Review 4.  Cytomegalovirus infection: a driving force in human T cell immunosenescence.

Authors:  Sven Koch; Anis Larbi; Dennis Ozcelik; Rafael Solana; Cécile Gouttefangeas; Sebastian Attig; Anders Wikby; Jan Strindhall; Claudio Franceschi; Graham Pawelec
Journal:  Ann N Y Acad Sci       Date:  2007-10       Impact factor: 5.691

5.  Resolution of severe Clostridium difficile infection following sequential fecal microbiota transplantation.

Authors:  Alexa R Weingarden; Matthew J Hamilton; Michael J Sadowsky; Alexander Khoruts
Journal:  J Clin Gastroenterol       Date:  2013-09       Impact factor: 3.062

6.  Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation.

Authors:  Sidhartha R Sinha; Yeneneh Haileselassie; Linh P Nguyen; Carolina Tropini; Min Wang; Laren S Becker; Davis Sim; Karolin Jarr; Estelle T Spear; Gulshan Singh; Hong Namkoong; Kyle Bittinger; Michael A Fischbach; Justin L Sonnenburg; Aida Habtezion
Journal:  Cell Host Microbe       Date:  2020-02-25       Impact factor: 21.023

7.  Functional microbiomics: Evaluation of gut microbiota-bile acid metabolism interactions in health and disease.

Authors:  Benjamin H Mullish; Alexandros Pechlivanis; Grace F Barker; Mark R Thursz; Julian R Marchesi; Julie A K McDonald
Journal:  Methods       Date:  2018-04-26       Impact factor: 3.608

8.  Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota.

Authors:  Julie A K McDonald; Benjamin H Mullish; Alexandros Pechlivanis; Zhigang Liu; Jerusa Brignardello; Dina Kao; Elaine Holmes; Jia V Li; Thomas B Clarke; Mark R Thursz; Julian R Marchesi
Journal:  Gastroenterology       Date:  2018-07-17       Impact factor: 22.682

Review 9.  The Immune Response Against Human Cytomegalovirus Links Cellular to Systemic Senescence.

Authors:  John J Heath; Michael D Grant
Journal:  Cells       Date:  2020-03-20       Impact factor: 6.600

10.  The gut microbiota is associated with immune cell dynamics in humans.

Authors:  Jonas Schluter; Jonathan U Peled; Bradford P Taylor; Kate A Markey; Melody Smith; Ying Taur; Rene Niehus; Anna Staffas; Anqi Dai; Emily Fontana; Luigi A Amoretti; Roberta J Wright; Sejal Morjaria; Maly Fenelus; Melissa S Pessin; Nelson J Chao; Meagan Lew; Lauren Bohannon; Amy Bush; Anthony D Sung; Tobias M Hohl; Miguel-Angel Perales; Marcel R M van den Brink; Joao B Xavier
Journal:  Nature       Date:  2020-11-25       Impact factor: 69.504

View more
  3 in total

Review 1.  The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases.

Authors:  Rohma Ghani; Benjamin H Mullish; Lauren A Roberts; Frances J Davies; Julian R Marchesi
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 2.  The interplay between Helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis.

Authors:  Farzaneh Fakharian; Behnoush Asgari; Ali Nabavi-Rad; Amir Sadeghi; Neda Soleimani; Abbas Yadegar; Mohammad Reza Zali
Journal:  Front Cell Infect Microbiol       Date:  2022-08-15       Impact factor: 6.073

Review 3.  Immunological mechanisms of fecal microbiota transplantation in recurrent Clostridioides difficile infection.

Authors:  Lucas F Soveral; Gabriela G Korczaguin; Pedro S Schmidt; Isabel S Nunes; Camilo Fernandes; Carlos R Zárate-Bladés
Journal:  World J Gastroenterol       Date:  2022-09-07       Impact factor: 5.374

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.